BioSpace News Archive

Amerigen Pharmaceuticals Limited (“Amerigen”) today announced that its Abbreviated New Drug Application (“ANDA”) for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration.

Merck announced the appointment of Jennifer Zachary as general counsel, effective April 16, 2018.

NovaBay Pharmaceuticals Inc reports financial results for the three and 12 months ended December 31, 2017 and provides a business update.

The Life Sciences division of AMPLEXOR has announced its March 2018 webinar program, with two webinars that aim to address challenges facing those in the life sciences industry.

Wuxi Biologics announced that it has selected 4,000 liter (L) Custom Single Run (CSR®) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China.

The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced that Novartis will have access to commercially develop their therapeutic, biomaterial-based, cancer vaccine technology that promotes anti-cancer immunity.

Oxford Nanopore Technologies Ltd has raised £100M ($140M) in new investment.

Essity has today published its Annual and Sustainability Report for 2017, available on www.essity.com.

Boston Scientific Corporation announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain.

BBK Worldwide (BBK), an industry leader in the clinical trial patient experience and engagement technologies, releases key performance metrics on its concierge services, revealing the significant impact these site- and patient-centric programs have on global clinical trial recruitment and engagement.